Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Blood Reviews
|
June 30, 2026
Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings
Tara Graff, Edward Pearson, Sairah Ahmed, et al.
Leukemia & Lymphoma
|
May 18, 2016
Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population
Shunan Qi, Joachim Yahalom, Meier Hsu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 21, 2023
Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience
Bryan Walker, Andrea J Zimmer, Erica J Stohs, et al.
Transportation Research Record
|
April 30, 2019
Electrophysiological Measure of Impaired Information Processing in Drivers with Hematological Malignancy
David E Anderson, Vijaya R Bhatt, Kendra Schmid, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 28, 2025
CLO25-054: Long Term Follow Up of Patients Undergoing High Dose Chemotherapy and Autologous or Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma
Sandra Amponsah Frimpong, Valerie Shostrom, Robert Gregory Bociek, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 6, 2016
Central nervous system involvement in T-cell lymphoma: A single center experience
Ronit Gurion, Neha Mehta, Jocelyn C Migliacci, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 17, 2022
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy
Paolo F Caimi, Kirit M Ardeshna, Erin Reid, et al.
Leukemia & Lymphoma
|
July 25, 2025
Matching-adjusted indirect comparison of lisocabtagene maraleucel versus axicabtagene ciloleucel for second-line treatment of patients with early relapsed or refractory large B-cell lymphoma
Jeremy S Abramson, Manali Kamdar, Fei Fei Liu, et al.
British Journal of Haematology
|
April 25, 2023
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study
Julie M Vose, Siddhartha Ganguly, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2020
Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe
Pelin Cinar, Timothy Kubal, Alison Freifeld, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Blood Reviews
|
June 30, 2026
Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings
Tara Graff, Edward Pearson, Sairah Ahmed, et al.
Leukemia & Lymphoma
|
May 18, 2016
Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population
Shunan Qi, Joachim Yahalom, Meier Hsu, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
November 21, 2023
Infectious complications among CD19 CAR-T cell therapy recipients: A single-center experience
Bryan Walker, Andrea J Zimmer, Erica J Stohs, et al.
Transportation Research Record
|
April 30, 2019
Electrophysiological Measure of Impaired Information Processing in Drivers with Hematological Malignancy
David E Anderson, Vijaya R Bhatt, Kendra Schmid, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 28, 2025
CLO25-054: Long Term Follow Up of Patients Undergoing High Dose Chemotherapy and Autologous or Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma
Sandra Amponsah Frimpong, Valerie Shostrom, Robert Gregory Bociek, et al.
Acta Oncologica (Stockholm, Sweden)
|
April 6, 2016
Central nervous system involvement in T-cell lymphoma: A single center experience
Ronit Gurion, Neha Mehta, Jocelyn C Migliacci, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 17, 2022
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy
Paolo F Caimi, Kirit M Ardeshna, Erin Reid, et al.
Leukemia & Lymphoma
|
July 25, 2025
Matching-adjusted indirect comparison of lisocabtagene maraleucel versus axicabtagene ciloleucel for second-line treatment of patients with early relapsed or refractory large B-cell lymphoma
Jeremy S Abramson, Manali Kamdar, Fei Fei Liu, et al.
British Journal of Haematology
|
April 25, 2023
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study
Julie M Vose, Siddhartha Ganguly, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 16, 2020
Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe
Pelin Cinar, Timothy Kubal, Alison Freifeld, et al.
Page
of 6